SEC Form 4 research
| Issuer | Amylyx Pharmaceuticals, Inc. |
|---|---|
| Tickers | AMLX |
| Reporting owners | 25 |
| Officers and directors | 13 |
| Last public filing | 2026-10-07 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-05 | MILNE GEORGE M JR | S | 30,000 | $27.7 | Not reported |
| 2026-09-14 | 2026-09-10 | Bedrosian Camille L | S | 2,081 | $33.09 | Not reported |
| 2026-09-14 | 2026-09-10 | Bedrosian Camille L | S | 7,947 | $32.21 | Not reported |
| 2026-09-14 | 2026-09-10 | FRATES JAMES M | S | 1,042 | $33.23 | Not reported |
| 2026-09-14 | 2026-09-10 | FRATES JAMES M | S | 9,768 | $32.27 | Not reported |
| 2026-09-14 | 2026-09-10 | Mazzariello Gina | S | 11 | $33.34 | Not reported |
| 2026-09-14 | 2026-09-10 | Mazzariello Gina | S | 9,525 | $32.46 | Not reported |
| 2026-09-14 | 2026-09-10 | Klee Justin B. | S | 1,439 | $33.16 | Not reported |
| 2026-09-14 | 2026-09-10 | Klee Justin B. | S | 29,025 | $32.13 | Not reported |
| 2026-09-14 | 2026-09-10 | Cohen Joshua B | S | 919 | $33.15 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.